newsfilter
← Latest News
PR Newswire·

REDUVO™ - A Major Milestone for Tetra Bio-Pharma Inc.

Tetra is gearing up to launch REDUVO™, its first cannabinoid-derived medicine, in Canada. REDUVO™ 5-year cumulative gross sales expected to reach $121M. The Company has started numerous pre-launch activities to prepare for the introduction of RE